Eplerenone: A Potassium-Sparing Diuretic for Heart Conditions

What is Eplerenone?

Eplerenone is a potassium-sparing diuretic medication that belongs to a class of drugs called selective aldosterone receptor antagonists. It is primarily used to treat high blood pressure and heart failure, particularly following a heart attack. Unlike other diuretics that cause potassium loss, eplerenone helps the body retain potassium while still promoting the elimination of excess sodium and water.

Uses

Eplerenone is approved for several cardiovascular conditions:

• High blood pressure (hypertension): Used alone or in combination with other blood pressure medications to reduce cardiovascular risk
• Heart failure after heart attack: Prescribed to patients with left ventricular dysfunction following myocardial infarction to improve survival rates
• Chronic heart failure: Added to standard heart failure therapy to reduce hospitalizations and mortality in patients with reduced ejection fraction
• Diabetic nephropathy: Sometimes used off-label to protect kidney function in diabetic patients with protein in their urine
• Primary aldosteronism: May be prescribed for patients with excessive aldosterone production causing resistant hypertension

How it works

Eplerenone works by selectively blocking aldosterone receptors in the kidneys, heart, and blood vessels. Aldosterone is a hormone that normally causes the body to retain sodium and water while losing potassium, which can increase blood pressure and strain the heart. By blocking these receptors, eplerenone prevents aldosterone’s effects, leading to increased sodium and water elimination while preserving potassium levels, ultimately reducing blood pressure and decreasing the workload on the heart.

Side effects

Common side effects include:

Submit Your Paper

• Dizziness or lightheadedness
• Headache
• Fatigue or weakness
• Diarrhea
• Nausea
• Flu-like symptoms
• Cough
• Abdominal pain

Serious side effects requiring immediate medical attention:

• High potassium levels (hyperkalemia) – muscle weakness, irregular heartbeat, numbness
• Kidney problems – decreased urination, swelling, confusion
• Severe dehydration – extreme thirst, dry mouth, little or no urination
• Allergic reactions – rash, swelling, difficulty breathing
• Severe electrolyte imbalances – muscle cramps, irregular heartbeat, seizures

Warnings and precautions

• Kidney function monitoring: Patients with kidney disease require careful monitoring as eplerenone can worsen kidney function and increase potassium levels to dangerous levels
• Pregnancy considerations: Classified as pregnancy category B, but should only be used when clearly needed and under medical supervision during pregnancy and breastfeeding
• Diabetes patients: Those with type 2 diabetes and kidney disease have increased risk of hyperkalemia and require more frequent monitoring
• Liver impairment: Patients with severe liver disease should avoid eplerenone as it may accumulate to toxic levels
• Elderly patients: Older adults may be more sensitive to the effects and require lower doses or more frequent monitoring

Interactions

Several medications and supplements can interact with eplerenone:

• ACE inhibitors and ARBs: Increase risk of high potassium levels when combined with eplerenone
• Potassium supplements: Can lead to dangerous hyperkalemia when taken together
• NSAIDs: May reduce eplerenone’s effectiveness and increase kidney damage risk
• Lithium: Eplerenone can increase lithium levels, potentially causing toxicity
• CYP3A4 inhibitors: Medications like ketoconazole and clarithromycin can increase eplerenone levels
• Salt substitutes: Many contain potassium and can contribute to hyperkalemia
• Trimethoprim-sulfamethoxazole: May increase potassium levels when used concurrently
• Heparin: Can suppress aldosterone production, increasing hyperkalemia risk

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated. For hypertension, the usual starting dose is 50 mg once daily, which may be increased to 50 mg twice daily if needed. For heart failure following heart attack, treatment typically begins with 25 mg once daily, gradually increasing to 50 mg once daily as tolerated. For chronic heart failure, the usual dose is 25-50 mg once daily. Dosages must be individualized based on kidney function, potassium levels, and patient response. All dosing decisions should be made by a qualified healthcare provider who will monitor blood pressure, kidney function, and electrolyte levels regularly.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).